MA33514B1 - Diagnostic d'une maladie parasitaire telle que la leishmaniose à l'aide d'un extrait de protéine ribosomique (rpe) - Google Patents

Diagnostic d'une maladie parasitaire telle que la leishmaniose à l'aide d'un extrait de protéine ribosomique (rpe)

Info

Publication number
MA33514B1
MA33514B1 MA34612A MA34612A MA33514B1 MA 33514 B1 MA33514 B1 MA 33514B1 MA 34612 A MA34612 A MA 34612A MA 34612 A MA34612 A MA 34612A MA 33514 B1 MA33514 B1 MA 33514B1
Authority
MA
Morocco
Prior art keywords
leishmaniasis
diagnosis
protein extracts
parasitic disease
ribosome protein
Prior art date
Application number
MA34612A
Other languages
Arabic (ar)
English (en)
Inventor
Manuel Soto-Álvarez
García Laura Ramírez
Eduardo Antonio Ferraz Coelho
Carlos Alonso-Bedate
Original Assignee
Leti Sl Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leti Sl Lab filed Critical Leti Sl Lab
Publication of MA33514B1 publication Critical patent/MA33514B1/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
  • Secondary Cells (AREA)

Abstract

L'INVENTION PORTE SUR UN PROCÉDÉ DE DIAGNOSTIC DE LEISHMANIOSE À L'AIDE D'UN RPE.
MA34612A 2009-07-13 2012-02-08 Diagnostic d'une maladie parasitaire telle que la leishmaniose à l'aide d'un extrait de protéine ribosomique (rpe) MA33514B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09165282 2009-07-13
US26721409P 2009-12-07 2009-12-07
PCT/EP2010/060058 WO2011006891A1 (fr) 2009-07-13 2010-07-13 Diagnostic d'une maladie parasitaire telle que la leishmaniose à l'aide d'un extrait de protéine ribosomique (rpe)

Publications (1)

Publication Number Publication Date
MA33514B1 true MA33514B1 (fr) 2012-08-01

Family

ID=41211952

Family Applications (1)

Application Number Title Priority Date Filing Date
MA34612A MA33514B1 (fr) 2009-07-13 2012-02-08 Diagnostic d'une maladie parasitaire telle que la leishmaniose à l'aide d'un extrait de protéine ribosomique (rpe)

Country Status (20)

Country Link
US (1) US8969019B2 (fr)
EP (1) EP2454593A1 (fr)
JP (1) JP5805635B2 (fr)
KR (1) KR20120061082A (fr)
CN (1) CN102483413A (fr)
AP (1) AP3516A (fr)
AU (1) AU2010272566B2 (fr)
BR (1) BR112012000679A2 (fr)
CA (1) CA2767865A1 (fr)
CO (1) CO6480993A2 (fr)
EC (1) ECSP12011662A (fr)
IL (1) IL217528A (fr)
IN (1) IN2012DN00401A (fr)
MA (1) MA33514B1 (fr)
MX (1) MX2012000675A (fr)
PE (1) PE20120818A1 (fr)
RU (1) RU2558233C2 (fr)
TN (1) TN2012000014A1 (fr)
WO (1) WO2011006891A1 (fr)
ZA (1) ZA201200295B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SA110310855B1 (ar) * 2009-11-13 2014-09-16 Laboratories Leti S L Unipersonal استخدام مصدر l3 و/ أو l5 كلقاح أو كوسيلة تشخيصية لمرض طفيلي
JP2016053535A (ja) * 2014-09-04 2016-04-14 国立大学法人 東京大学 皮膚型リーシュマニア症の検査用試薬又はキット、及び皮膚型リーシュマニア症の検査方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5359681A (en) 1993-01-11 1994-10-25 University Of Washington Fiber optic sensor and methods and apparatus relating thereto
US5912166A (en) 1995-04-21 1999-06-15 Corixa Corporation Compounds and methods for diagnosis of leishmaniasis
US6500437B1 (en) * 1995-09-22 2002-12-31 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US6613337B1 (en) 1997-02-12 2003-09-02 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
CN1158387C (zh) * 1998-12-23 2004-07-21 C.B.F.莱蒂股份有限公司 编码l.infantum的四种蛋白质的抗原决定簇的嵌合基因
EP1624063B1 (fr) 1998-12-23 2009-04-22 Laboratorios LETI, S.L. Gène chimérique formé par les séquences d'adn codant pour les déterminants antigéniques de quatre protéines de L. infantum
ES2169995B1 (es) 2000-04-17 2003-12-01 Leti Lab Composicion a base de la proteina lip2a y su uso en la preparacion de un medicamento para suscitar una respuesta inmune contra un antigeno.
AU2003270274B2 (en) * 2002-09-20 2009-03-19 Intervet International B.V. Live attenuated parasite vaccine
EP1687023B1 (fr) 2003-11-05 2012-10-03 C.B.F. Leti, S.L. Unipersonal Application d'histones specifiques au traitement de maladies parasitaires

Also Published As

Publication number Publication date
EP2454593A1 (fr) 2012-05-23
MX2012000675A (es) 2012-06-08
PE20120818A1 (es) 2012-07-12
KR20120061082A (ko) 2012-06-12
TN2012000014A1 (en) 2013-09-19
CA2767865A1 (fr) 2011-01-20
RU2012104855A (ru) 2013-08-20
ZA201200295B (en) 2012-09-26
US20120178109A1 (en) 2012-07-12
CN102483413A (zh) 2012-05-30
JP2012533074A (ja) 2012-12-20
RU2558233C2 (ru) 2015-07-27
ECSP12011662A (es) 2012-06-29
AU2010272566B2 (en) 2015-03-26
JP5805635B2 (ja) 2015-11-04
IL217528A0 (en) 2012-02-29
WO2011006891A1 (fr) 2011-01-20
AP3516A (en) 2016-01-11
CO6480993A2 (es) 2012-07-16
IN2012DN00401A (fr) 2015-08-21
AP2012006118A0 (en) 2012-02-29
BR112012000679A2 (pt) 2016-11-01
AU2010272566A1 (en) 2012-02-02
US8969019B2 (en) 2015-03-03
IL217528A (en) 2016-05-31

Similar Documents

Publication Publication Date Title
AR066987A1 (es) Anticuerpo monoclonal contra proteina beta-amiloide
FR2899480B1 (fr) Systeme de desinfection d'instruments medicaux
DE602008003369D1 (de) Gelenkverbindung für chirurgische Instrumente
BRPI1012993A2 (pt) "uso de um anticorpo anti-tau ps422 para o tratamento de doenças do cérebro"
IT1400759B1 (it) Apparecchio semovente nonche' procedimento per la guida a destinazione di detto apparecchio
UY32535A (es) Métodos e intermediarios para la preparación de agentes farmacéuticos
ES2338590T3 (es) Procedimiento regioselectivo de preparacion de benzoimidazoltiofenos.
FI20115576A0 (fi) Menetelmä Alzheimerin taudin diagnoimiseksi
CL2007003158A1 (es) Procedimiento de preparacion de compuestos derivados de quinazolina o sus sales farmaceuticamente aceptables; compuestos intermediarios; procedimiento de preparacion.
FR2946863B1 (fr) Ensemble de reconstruction d'une articulation de l'epaule fracturee.
IL231620A0 (en) A method for diagnosing Alzheimer's disease
BR112014000637A2 (pt) diagnóstico do mal de alzheimer
BRPI0913477A2 (pt) "método para desenvolvimento de marcador diagnóstico"
FR2914636B1 (fr) Procede de preparation d'une zeolithe beta
DE502006005715D1 (de) Justierbare Okulareinheit für Endoskope
BRPI0514053A (pt) método para aumentar a tolerabilidade das plantas frente ao glifosato
MA33514B1 (fr) Diagnostic d'une maladie parasitaire telle que la leishmaniose à l'aide d'un extrait de protéine ribosomique (rpe)
BRPI1013003A2 (pt) "disposições de acoplamento e métodos para fixação de ferramentas a instrumentos cirúrgicos ultra-sônicos"
ATE402610T1 (de) Legenest für geflügel
AP2012006275A0 (en) The use of an L3 and/or L5 source as a vaccine or as a diagnostic for a parasitic disease.
ECSP099045A (es) Sal xinafoato de un compuesto de 5-oxazol-2-il-quinolina sustituido
FR2904671B1 (fr) Systeme d'articulation instrumente.
BR112012002077A2 (pt) processos e métodos para diagnóstico de doença de alzheimer
FR2949472B1 (fr) Proteines utilisees pour le diagnostic d'une borreliose de lyme
FR2907875B1 (fr) "collier de fixation d'un conduit"